COMMENTARY
<Special Contribution> Global Products Enhance Dominance in Japan with Local Products Confined to Niche Markets
Sugio SekoPresidentPharma Marketing Survey Research LaboratoryStrategic global products (G-Pr) have been recently increasing their market dominance in Japan as well as in overseas markets, and major foreign-affiliated companies, which have enhanced their power through major M&As, are attacking Japan, the…
To read the full story
COMMENTARY
- FY2026 Reform Debate for Drug Pricing Nears the Finish Line, Balance Needed
December 9, 2025
- MOF Autumn Proposals Signal a Shift from Drug Pricing to Cost-Sharing Reform
November 17, 2025
- Japan’s Trading Houses Gain Ground in Pharma, Rewriting the Industry Playbook
November 10, 2025
- The Price of Stability: Who Bears Japan’s Drug Distribution Burden?
October 27, 2025
- Inside Eylea - 2: Will a Bio-AG Return after Six Years? Pricing Debate Resumes
October 7, 2025
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…





